Cite
HARVARD Citation
Waldeck, S. et al. (2020). CCL5 mediates target‐kinase independent resistance to FLT3 inhibitors in FLT3‐ITD‐positive AML. Molecular oncology. 14 (4), pp. 779-794. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Waldeck, S. et al. (2020). CCL5 mediates target‐kinase independent resistance to FLT3 inhibitors in FLT3‐ITD‐positive AML. Molecular oncology. 14 (4), pp. 779-794. [Online].